Ads
    Related paper
  1. Correction of Dyslipidemia in Patients with Coronary Heart Disease Combined with Nonalcoholic Fatty Liver Disease
  2. The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
  3. Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of secondary prevention
  4. The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
  5. TELMISARTAN PLUS ATORVASTATIN INFLUENCE ON ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
  6. Statistical Neural Networks in the Classification of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease
  7. DYSLIPIDEMIA AS A FACTOR FOR PROGRESSION OF RENAL OSTEODYSTROPHY AND CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON PERITONEAL DIALYSIS
  8. CHANGES RANGE OF FATTY ACID PLATELETS PHOSPHOLIPID MEMBRANES IN CORONARY HEART DISEASE COMBINED WITH PAROXYSMAL ATRIAL FIBRILLATION PATIENTS
  9. Peculiarities of Gout Progression in Patients with Nonalcoholic Fatty Liver Disease
  10. Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetic patients in correlation with coronary artery disease